Therapeutical and Research Center of Lung Tumor

Overview

The Therapeutical and Research Center of Lung Tumor includes LDCT team, precision surgery team, interventional treatment team, and precision cancer medicine team. The Therapeutical and Research Center of Lung Tumor works together to evaluate and develop a personalized treatment plan for patients with lung cancer. Various treatment modalities, such as surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapy could be provided integrally.

Features Summary

Malignancy composes the top ten causes of death, and lung cancer accounts for nearly 20% of all cancer deaths. The reason is that most early stage lung cancers are asymptomatic, and about 70% of patients diagnosed with lung cancer due to symptoms have local or distant metastases. The Therapeutical and Research Center of Lung Tumor includes low dose computed tomography (LDCT) diagnosis team, precision surgery team, interventional treatment team, and precision cancer medicine tream. It is composed of directors of relevant departments, medical staff, and technical personnel, and is included in the multidisciplinary team of thoracic oncology.

Precision medicine, also known as personalized medicine, is a rapidly evolving field that has revolutionized the way we diagnose and treat lung cancer. The goal of precision medicine is to tailor medical treatment to the individual characteristics of each patient, considering genetic, environmental, and lifestyle factors. With the advancement of genomic sequencing technologies, we can now identify specific genetic mutations that drive the growth of lung cancer tumors, allowing us to design targeted treatments that can be more effective and have fewer side effects. Precision medicine has already had a significant impact on the treatment of lung cancer and has led to the development of new drugs and treatment approaches that are specifically designed for individual patients. By leveraging this novel approach, we can not only improve patient outcomes, but also reduce the risk of treatment failure, reduce costs, and improve the quality of life for patients living with lung cancer.

Procedure

Low-dose CT (computed tomography) is a medical imaging test that uses a small amount of ionizing radiation to create detailed images of the body, particularly the lungs. It is used for lung cancer screening in individuals who are at high risk of developing the disease, such as long-term smokers. The low-dose CT scan uses a lower amount of radiation compared to a regular CT scan, reducing the potential risk of radiation exposure. This type of screening can detect lung cancer in its early stage, when it is most treatable, and can lead to improved survival rates for patients. However, like all medical procedures, low-dose CT carries some risks, and it's important to discuss the potential benefits and risks with a doctor before undergoing the test. The precision cancer medicine could be provided by using next-generation sequencing (NGS) test to develop treatment approaches that are specifically designed for individual patients.

Notification

Low-dose CT (LDCT) is a safe and effective tool for lung cancer screening, but like all medical procedures, it carries some risks. The most significant risk of LDCT is the potential exposure to ionizing radiation, which can increase the risk of cancer over time. However, the radiation exposure from a LDCT scan is significantly lower than that of a regular CT scan and is considered to be a low risk examination to most people. Other potential risks of LDCT include false-positive results that can lead to unnecessary additional testing and procedures, and the detection of incidental findings that may require follow-up but are not related to lung cancer. It's important to discuss the potential benefits and risks of LDCT with a healthcare professional and determine if it is appropriate for an individual's specific situation.

If abnormal findings are found, the LDCT team would discuss on further diagnostic and treatment plans, such as biopsy, surgery, and systemic therapy.

International Medical Service Center